Standardized Documentation and Assessments for Polycythemia Vera: A Quality Improvement Initiative
Starting soon · Not applicable
Conditions studied: Polycythemia Vera
In brief
The purpose of this quality improvement initiative is to explore whether an electronic medical records-based templated progress note for polycythemia vera (PV) in addition to a standard-of-care pharmacist-collaborative ropeginterferon alfa-2b titration service is feasible, acceptable, and appropriate for clinicians who manage PV.
Key facts
- Study ID
- NCT07734272
- Run by
- Massachusetts General Hospital
- People needed
- 32
- Starts
- 2026-08-05
- Expected to finish
- 2028-03-31
- Last updated by the study team
- 2026-07-29
Who can join
Age: any. Sex: any. Healthy volunteers: accepted.
You may qualify if…
- Hematologists and medical oncologists within the Mass General Brigham network sites who treat at least one patient with PV in their outpatient clinic.
You may not qualify if…
- Clinicians who do not have an outpatient hematology or medical oncology clinic within Mass General Brigham.
- Clinicians who do not utilize the EPIC electronic medical record (EMR) System as their method of patient progress note documentation.
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.